Results 281 to 290 of about 813,681 (302)
Some of the next articles are maybe not open access.
, 2018
Background: Diabetes is a complex, chronic illness requiring continuous medical care with multifactorial risk-reduction strategies beyond glycemic control.
A. Osamah+3 more
semanticscholar +1 more source
Background: Diabetes is a complex, chronic illness requiring continuous medical care with multifactorial risk-reduction strategies beyond glycemic control.
A. Osamah+3 more
semanticscholar +1 more source
Clinical science, 2000
This study was conducted to evaluate the influence of proinsulin C-peptide on erythrocyte Na(+),K(+)-ATPase and endothelial nitric oxide synthase activities in patients with type I diabetes.
T. Forst+12 more
semanticscholar +1 more source
This study was conducted to evaluate the influence of proinsulin C-peptide on erythrocyte Na(+),K(+)-ATPase and endothelial nitric oxide synthase activities in patients with type I diabetes.
T. Forst+12 more
semanticscholar +1 more source
Klinische Wochenschrift, 1984
In vitro measurements were carried out to study the aggregation of erythrocytes in 33 children and young adolescents, three older adolescents, and 38 adults with type I diabetes. The aggregate formation of erythrocytes in stasis was increased in adult patients with both "good" and "poor" metabolic control when compared to control values.
Max Lakomek+4 more
openaire +3 more sources
In vitro measurements were carried out to study the aggregation of erythrocytes in 33 children and young adolescents, three older adolescents, and 38 adults with type I diabetes. The aggregate formation of erythrocytes in stasis was increased in adult patients with both "good" and "poor" metabolic control when compared to control values.
Max Lakomek+4 more
openaire +3 more sources
Russian Clinical Laboratory Diagnostics, 2017
The article presents results of the study of electrophoretic agility of erythrocytes, their pro-oxidant characteristics and intra-cellular concentration of adenosine triphosphate (ATP) and 2,3-diphosphoglycerate (2,3-DPG) in patients with diabetes ...
A. Deryugina+3 more
semanticscholar +1 more source
The article presents results of the study of electrophoretic agility of erythrocytes, their pro-oxidant characteristics and intra-cellular concentration of adenosine triphosphate (ATP) and 2,3-diphosphoglycerate (2,3-DPG) in patients with diabetes ...
A. Deryugina+3 more
semanticscholar +1 more source
Clinical Nephrology, 2004
BACKGROUND The proportion of diabetics among patients requiring renal replacement therapy continues to increase in most western countries. The acceptance rate for renal transplantation varies among transplant centers and is influenced by the current ...
V. Lufft+4 more
semanticscholar +1 more source
BACKGROUND The proportion of diabetics among patients requiring renal replacement therapy continues to increase in most western countries. The acceptance rate for renal transplantation varies among transplant centers and is influenced by the current ...
V. Lufft+4 more
semanticscholar +1 more source
A Robust Approach to Control Blood Glucose Level: Diabetes Mellitus Type I
IFAC Proceedings Volumes, 2003Abstract H∞ control is applied for the insulin delivery to prevent the hyperglycemic levels in a Type I diabetic patient. From a control theory point of view, the blood glucose regulation problem is reformulated as a tracking one. A glucose tolerance curve (GTC), validated from healthy subjects, is used as reference signal.
R. Femat+2 more
openaire +2 more sources
Stem Cell Transplantation in Diabetes Mellitus Type I and Type II
2017This chapter reviews significant advances in the transplantation of stem cell-derived insulin-producing cells in diabetes mellitus type I and type II. The successful outcome has been achieved in the standardization of stem cell identification, isolation, purification, differentiation, expansion, and storage procedures.
Sicong Tu, Jian Tu
openaire +2 more sources
Thrombocyting haemostasis in children with diabetes mellitus type I
Endocrine Abstracts, 2020Vadim Poliakov+5 more
openaire +2 more sources
[Prolactin secretion in diabetic nephropathy of patients with diabetes mellitus type I (IDDM)].
Polskie Archiwum Medycyny Wewnetrznej, 1996Disturbances of prolactin secretion occur both in the chronic renal failure and in diabetes mellitus. The study aimed to investigate if the diabetic nephropathy as a cause of chronic renal failure disturbs prolactin secretion. The study was conducted in 5 groups of patients: group I-12 patients with IDDM without diabetic nephropathy; group II-12 ...
E, Zukowska-Szczechowska+3 more
openaire +1 more source
Longitudinal growth in children with diabetes mellitus type I
Canadian Journal of Diabetes, 2009R. Calzada+6 more
openaire +2 more sources